# US 9,517,277 B2 · Immune-stimulating photoactive hybrid nanoparticles

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 9,517,277 B2
- Document ID: US9517277B2
- Status: Granted
- Kind: B2
- Application number: 14/128,238
- Filed: 2012-07-11
- Published: 2014-08-07
- Granted: 2016-12-13
- Earliest claimed: 2011-07-15
- Assignees: University of Georgia Research Foundation, Inc.
- Applicants: Shanta Dhar; Joshua Choi; Sean Marrache
- Inventors: Shanta Dhar; Joshua Choi; Sean Marrache
- Web page: https://patentgrep.com/patent/US9517277B2

## CPC

- A61K 41/0071: {PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines}
- A61P 35/00: Antineoplastic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Provides is a therapeutic technology that combines the phototoxic and immune-stimulating ability of photodynamic therapy with the widespread effectiveness of the immune system to reduce the viability of such as cancer cells and tumors. The nanoparticle compositions of the disclosure combine an immunostimulant with a photosensitizer using a nanoparticle delivery platform. For example, zinc pthalocyanine, which is a long-wavelength absorbing photosensitizer, integrated into a polymeric nanoparticle core made up of poly(D,L-lactic-co-glycolic acid)-b-poly(ethylene glycol) (PLGA-b-PEG). The outside surface of the core can be coated with metallic nanoparticles, which are then modified with CpG-ODN. Metastatic mouse breast carcinoma cells showed significant photocytotoxicity of the hybrid after irradiation with a 660 nm LASER light and this activity was remarkably better than either treatment alone. Treatment of mouse bone marrow derived dendritic cells with the photodynamic therapy-killed 4T1 cell lysate showed that the combination of photodynamic therapy with a synergistic immunostimulant in a single nanoparticle system resulted in an immune response suitable for the treatment of such as a metastatic cancer.

## Claims

### Claim 1

A multifunctional hybrid nanoparticle, comprising a nanoparticle core comprising a photosensitizer and a polymer, a plurality of metallic nanoparticles disposed on the surface of the nanoparticle core, and an immunostimulant disposed on the plurality of metallic nanoparticles, wherein the photosensitizer is zinc phthalocyanine, the nanoparticle core comprises a biodegradable polymer of poly (D,L-lactic-co-glycolic acid)-b-poly(ethylene glycol), the metallic nanoparticles are gold nanoparticles, and the immunostimulant disposed on the metallic nanoparticles is a CpG-ODN.

### Claim 2

A method of reducing the viability of a cell comprising the steps of:
(i) administering to an animal or human subject a pharmaceutically acceptable composition comprising a multifunctional hybrid nanoparticle comprising a nanoparticle core comprising a photosensitizer and a polymer, a plurality of metallic nanoparticles disposed on the surface of the nanoparticle core; and an immunostimulant disposed on the metallic nanoparticles, and wherein the immunostimulant generates an immune response in the animal or human subject that reduces the viability of a cancerous cell or a tumor, wherein the photosensitizer is zinc phthalocyanine, the nanoparticle core comprises a biodegradable polymer of poly (D,L-lactic-co-glycolic acid)-b-poly(ethylene glycol), the metallic nanoparticles are gold nanoparticles, and the immunostimulant disposed on the metallic nanoparticles is a CpG-ODN; and
(ii) irradiating the cell with a light energy having a wavelength generating a photoacitvated oxygen species by the photosensitizer.

### Claim 3

A pharmaceutically acceptable composition comprising a multifunctional hybrid nanoparticle comprising a nanoparticle core comprising a photosensitizer and a polymer; a plurality of a metallic nanoparticle disposed on the surface of the nanoparticle core; and an immunostimulant disposed on the surfaces of the plurality of metallic nanoparticles, wherein the photosensitizer is zinc pthalocyanine, the nanoparticle core comprises a biodegradable polymer of poly (D,L-lactic-co-glycolic acid)-b-poly(ethylene glycol), the metallic nanoparticles are gold nanoparticles, and the immunostimulant disposed on the metallic nanoparticles is CpG-ODN; and a pharmaceutically acceptable carrier.